Characteristics and treatment of nonagenarian patients with vascular disease admitted to internal medicine services. NONAVASC-2 registry

Rev Clin Esp (Barc). 2023 Nov;223(9):569-577. doi: 10.1016/j.rceng.2023.09.005. Epub 2023 Sep 16.

Abstract

Introduction: Vascular disease (VD) is the most frequent cause of morbidity and mortality and its prevalence increases with age. Old patients are not included in studies on VD, their characteristics and treatments being unknown.

Objective: Know the clinical characteristics of nonagenarian patients hospitalized in Internal Medicine services with a diagnosis of established VD and the adequacy of their pharmacological management.

Material and methods: The NONAVASC-2 registry is an observational, prospective, multicentre study. Hospitalized patients for any cause were included. Data collection was carried out through an anonymous online database with sociodemographic, clinical, analytical, therapeutic and evolutionary parameters.

Results: One thousand forty-nine patients with a mean age of 93.14 years (57.8% women) were included. The prevalence of risk factors and VD was high: hypertension (84.9%), dyslipidemia (50.9%) and diabetes mellitus (29.4%). 33.4% presented severe-total dependency. 82.9% received antithrombotic treatment (53.7% antiplatelets, 25.4% anticoagulation and 3.8% double therapy). Only 38.2% received statins. The percentage of severe dependence (39.2% vs 24.1%; p = 0.00) and severe cognitive impairment (30.8% vs 13.8%; p = 0.00) was significantly higher among patients who did not receive them. 19% died during admission.

Conclusions: Nonagenarian patients with VD present high comorbidity, dependence and mortality. Despite being in secondary prevention, 17% did not receive antithrombotics and only 38% received statins. The underprescription is conditioned, among other factors, by the functional status. More studies are necessary to determine the impact of this issue on their prognosis.

Keywords: Anciano; Elderly; Hospitalización; Hospitalization; Internal medicine; Medicina interna; Nonagenarian; Nonagenario; Prevención secundaria; Riesgo vascular; Secondary prevention; Tratamiento; Treatment; Vascular risk.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged, 80 and over
  • Female
  • Hospitalization
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Male
  • Nonagenarians
  • Prospective Studies
  • Registries
  • Vascular Diseases* / epidemiology
  • Vascular Diseases* / therapy

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors